logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 5-chloro-4-hydroxy-1H-pyridin-2-one CAS 103766-25-2

5-chloro-4-hydroxy-1H-pyridin-2-one CAS 103766-25-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 103766-25-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

5-chloro-4-hydroxy-1H-pyridin-2-one

,

CAS 103766-25-2 5-chloro-4-hydroxy-1H-pyridin-2-one

CAS NO::
103766-25-2
Appearance::
Off-white Solid
Molecular Formula::
C5H4ClNO2
Molecular Weight::
145.54400
EINECS NO::
NA
MDL NO::
MFCD08458352
CAS NO::
103766-25-2
Appearance::
Off-white Solid
Molecular Formula::
C5H4ClNO2
Molecular Weight::
145.54400
EINECS NO::
NA
MDL NO::
MFCD08458352
5-chloro-4-hydroxy-1H-pyridin-2-one CAS 103766-25-2

Product Description:

Product Name: 5-chloro-4-hydroxy-1H-pyridin-2-one CAS NO: 103766-25-2

 

 

Synonyms:

2,4-dihydroxy-5-chloropyridine;

5-Chloro-2,4-pyridinediol;

5-Chloro-2,4-dihydroxypyridine;

 

 

Chemical & Physical Properties:

Appearance: Off-white solid

Assay :≥99.0%

Density: 1.56 g/cm3

Boiling Point: 281.9℃ at 760 mmHg

Melting Point: 274℃

Flash Point: 124.3℃

Refractive Index: 1.617

Vapor Pressure: 0.000408mmHg at 25℃

Storage Condition: Refrigerator

 

 

Safety Information:

Hazard Class: 3

Safety Statements: S16; S26; S33; S36/37/39

HS Code: 2942000000

WGK Germany: 1

Packing Group: II

RIDADR: UN 2985 3/PG 2

Risk Statements: R11; R14; R34

Hazard Codes: F; C

 

 

Gimeracil(Gimestat) is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which degrades pyrimidine including 5-fluorouracil in the blood; inhibits homologous recombination.IC50 Value: Target: DPYDin vitro: Gimeracil had radiosensitizing effects by partially inhibiting homologous recombination (HR) in the repair of DNA double strand breaks. Tail moments in neutral comet assay increased in gimeracil-treated cells. Gimeracil restrained the formation of foci of Rad51 and replication protein A (RPA), whereas it increased the number of foci of Nbs1, Mre11, Rad50, and FancD2. Gimeracil did not sensitize DPYD-depleted cells. Gimeracil inhibited DNA DSB repair. It did not sensitize cells deficient in HR but sensitized those deficient in NHEJ. In SCneo assay, Gimeracil reduced the frequency of neo-positive clones. Additionally, it sensitized the cells in S-phase more than in G0/G1.in vivo:

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.